ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%
Tue, 23 Oct

ALEMBIC PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m7,8938,62511,27130.7%42.8%
Other incomeRs m771242270.0%-69.1%
TurnoverRs m7,9708,62611,29430.9%41.7%
ExpensesRs m6,1017,1158,24715.9%35.2%
Gross profitRs m1,7911,5103,023100.2%68.8%
DepreciationRs m2572762863.7%11.6%
InterestRs m41658270.1%1560.0%
Profit before taxRs m1,6081,2202,703121.6%68.1%
TaxRs m366315703122.9%92.2%
Profit after taxRs m1,2429042,000121.2%61.0%
Gross profit margin%22.717.526.8
Effective tax rate%22.725.926.0
Net profit margin%15.610.517.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 42.8% on a year-on-year (YoY) basis. The expenses were up by 35.2% YoY during the same period.
  • The company's operating profit increased by 68.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 2QFY19 as against 22.7% in 2QFY18.
  • Depreciation charges and finance costs increased by 11.6% YoY and 1560.0% YoY, respectively.
  • Other income declined by 69.1% YoY during the quarter.
  • Net profit for the quarter increased by 61.0% YoY. Net profit margins during the quarter increased from 15.6% in 2QFY18 to 17.7% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 30.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 15.9% QoQ during the same period.
  • The company's operating profit increased by 100.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 2QFY19 as against 17.5% in 1QFY18.
  • Net profit for the quarter increased by 121.2% QoQ, while net profit margins increased from 10.5% in 1QFY18 to 17.7% in 2QFY19.

To see how ALEMBIC PHARMA has performed over the last eight quarters, please visit here.

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 496.0 to Rs 575.0, registering a Gain of Rs 79.1 or around 15.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,438.9 (down 0.5%). Over the last one year it has moved up from 14,047.3 to 14,438.9, a gain of 392 points (up 2.8%).

Overall, the S&P BSE SENSEX is up 4.6% over the year.

Current Valuations

At the current price of Rs 575.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 20.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.9 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 20, 2020 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS